Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor.

Journal of biochemical and molecular toxicology - 1 Dec 2020

Khodaei Forouzan, Ahsan Anam, Chamanifard Mostafa, Zamiri Mohammad Javad, Ommati Mohammad Mehdi

Abstract excerpt

The new coronavirus (COVID-19) was first reported in Wuhan in China, on 31 December 2019. COVID-19 is a new virus from the family of coronaviruses that can cause symptoms ranging from a simple cold to pneumonia. The virus is thought to bind to the angiotensin-converting enzyme 2, as a well-known mechanism to enter the cell. It then transfers its DNA to the host in which the virus replicates the DNA. The viral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Antioxidants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Dietary Supplements

Share to Immunologic Factors

Share to Medicine, Chinese Traditional

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 32770858
DOI: 10.1002/jbt.22594
PMCID: PMC7435514

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor.PMID 32770858Read ↗

Molecular Mechanism of Coronaviruses (COVID-19) and Diagnostic ApproachesSemantic proximity Read ↗

SARS-CoV-2: basic concepts, origin and treatment advancesSemantic proximity Read ↗

Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research.Semantic proximity Read ↗

A Network Pharmacology-based Analysis of the Molecular Mechanism of Tanreqing in the Treatment of the Coronavirus Disease 2019 (COVID-19)Semantic proximity Read ↗

<strong>Pathogenesis, Diagnosis and Possible Therapeutic Options for COVID-19</strong>Semantic proximity Read ↗

Ontological and Bioinformatic Analysis of Anti-Coronavirus Drugs and Their Implication for Drug Repurposing against COVID-19Semantic proximity Read ↗

COVID-19 Infection: Targeting Possibilities for Treatment.Semantic proximity Read ↗

Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin SystemSemantic proximity Read ↗

Focusing on the Unfolded Protein Response and Autophagy Related Pathways to Reposition Common Approved Drugs against COVID-19Semantic proximity Read ↗

The Mechanism of Chaiyin Particles in the Treatment of COVID-19 Based on Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infectionSemantic proximity Read ↗

Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.